89bio Inc (NASDAQ: ETNB) on Monday, soared 6.63% from the previous trading day, before settling in for the closing price of $6.94. Within the past 52 weeks, ETNB’s price has moved between $4.16 and $11.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 42.05%. With a float of $140.34 million, this company’s outstanding shares have now reached $145.98 million.
In an organization with 93 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
89bio Inc (ETNB) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of 89bio Inc is 3.86%, while institutional ownership is 89.90%. The most recent insider transaction that took place on Apr 15 ’25, was worth 91,208. In this transaction an insider of this company sold 15,329 shares at a rate of $5.95, taking the stock ownership to the 328,323 shares. Before that another transaction happened on Apr 15 ’25, when Company’s Officer proposed sale 15,329 for $5.95, making the entire transaction worth $91,171.
89bio Inc (ETNB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.45% during the next five years compared to 32.21% growth over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
89bio Inc (ETNB) is currently performing well based on its current performance indicators. A quick ratio of 13.19 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.43, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.07 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
Let’s dig in a bit further. During the last 5-days, its volume was 1.11 million. That was inferior than the volume of 2.32 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 92.92%. Additionally, its Average True Range was 0.64.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 42.19%, which indicates a significant decrease from 98.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 108.18% in the past 14 days, which was higher than the 99.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.88, while its 200-day Moving Average is $8.26. However, in the short run, 89bio Inc’s stock first resistance to watch stands at $7.59. Second resistance stands at $7.79. The third major resistance level sits at $8.12. If the price goes on to break the first support level at $7.06, it is likely to go to the next support level at $6.73. The third support level lies at $6.53 if the price breaches the second support level.
89bio Inc (NASDAQ: ETNB) Key Stats
Market capitalization of the company is 1.08 billion based on 145,984K outstanding shares. Right now, sales total 0 K and income totals -367,080 K. The company made 0 K in profit during its latest quarter, and -118,350 K in sales during its previous quarter.
